Up-Front Multigene Panel Testing for Cancer Susceptibility in Patients With Newly Diagnosed Endometrial Cancer: A Multicenter Prospective Study

Clinical utility of up-front multigene panel testing (MGPT) is directly related to the frequency of pathogenic variants (PVs) in the population screened and how genetic findings can be used to guide treatment decision making and cancer prevention efforts. The benefit of MGPT for many common malignan...

Descripción completa

Detalles Bibliográficos
Autores principales: Levine, Monica D., Pearlman, Rachel, Hampel, Heather, Cosgrove, Casey, Cohn, David, Chassen, Alexis, Suarez, Adrian, Barrington, David A., McElroy, Joseph P., Waggoner, Steven, Nakayama, John, Billingsley, Caroline, Resnick, Kim, Andrews, Stephen, Singh, Sareena, Jenison, Eric, Clements, Aine, Neff, Robert, Goodfellow, Paul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2021
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9848552/
https://www.ncbi.nlm.nih.gov/pubmed/34994648
http://dx.doi.org/10.1200/PO.21.00249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9848552/
https://www.ncbi.nlm.nih.gov/pubmed/34994648
http://dx.doi.org/10.1200/PO.21.00249

Ejemplares similares